Table 5. Funding of the UK papers cited by cancer clinical guidelines (G refs), grouped by RL (integer counts).
RL: G refs | G refs | % | GOV-O | GOV-C | PNP-O | PNP-C | CRUK-O | CRUK-C |
---|---|---|---|---|---|---|---|---|
1–1.5 | 544 | 69 | 149 | 60 | 198 | 129 | 142 | 73 |
1.5–2 | 127 | 16 | 26 | 16 | 49 | 40 | 39 | 19 |
2–2.5 | 83 | 11 | 13 | 15 | 46 | 47 | 33 | 28 |
2.5–3 | 19 | 2 | 4 | 3 | 13 | 11 | 9 | 5 |
3–3.5 | 13 | 2 | 2 | 3 | 5 | 7 | 3 | 4 |
3.5–4 | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 0 |
Total | 787 | 100 | 195 | 98 | 312 | 234 | 226 | 128 |
Obs/Calc | 1.99 | 1.33 | 1.76 | |||||
RL: G refs | G refs | % | Pharm-O | Pharm-C | Indy-O | Indy-C | None-O | None-C |
1–1.5 | 544 | 69 | 116 | 33 | 25 | 16 | 156 | 326 |
1.5–2 | 127 | 16 | 19 | 12 | 8 | 5 | 40 | 60 |
2–2.5 | 83 | 11 | 18 | 13 | 8 | 4 | 21 | 18 |
2.5–3 | 19 | 2 | 0 | 2 | 1 | 1 | 4 | 4 |
3–3.5 | 13 | 2 | 3 | 2 | 0 | 1 | 3 | 2 |
3.5–4 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 787 | 100 | 156 | 62 | 42 | 26 | 224 | 409 |
Obs/Calc | 2.53 | 1.63 | 0.55 |
C=calculated on basis of ONCOL papers; O=observed number of papers. Columns may not add correctly because of rounding. Other column headings as in Table 4.